Daily HIV PrEP in the form of a pill is a readily available, highly effective prevention option. Newer choices are becoming available but research suggests that users are still most drawn to using the daily dose medication.

HIV self-testing kits have been making headlines lately because they empower individuals and supposedly make testing more accessible. Is this really so? Statistics suggest that the effectiveness of this prevention approach may not be as high as originally anticipated.

PrEP use during pregnancy hasn’t been studied so far. A new study provides insightful information about the safety of antiretroviral medications used to diminish the risk of contracting HIV in the event of exposure. Researchers found out that PrEP use during pregnancy is not linked to adverse outcomes.

HIV-positive individuals have to take their daily dose of antiretroviral medications to suppress the virus and keep it from replicating. Researchers are now experimenting with a new gel-like formula that will completely eliminate the need for taking a daily dose.

PrEP use during pregnancy hasn’t been studied so far. A new study provides insightful information about the safety of antiretroviral medications used to diminish the risk of contracting HIV in the event of exposure. Researchers found out that PrEP use during pregnancy is not linked to adverse outcomes.

Genetics play an important role in the way we respond to pathogens like the human immunodeficiency virus. A new study among people of African descent suggests that certain genetic variants supress the viral load of people who have a chronic HIV infection. These variants also reduce the risk of viral transmission.

The development of antiretroviral therapy (ART) is one of the most defining discoveries in the fight against HIV. New data and WHO recommendations suggest that the widespread ART administration among HIV-positive individuals is the best option for improving individual health outcomes and eliminating the risk of transmission.

The latest numbers pertaining to HIV infections in Singapore are consistent with international findings. For several years in a row, the rate of new infections has been declining. In fact, the 2022 figure has been the lowest one since 1998.